Dementia risk reduction assessed with ANU‐ADRI in the <i>Maintain Your Brain</i> trial, an online multidomain intervention to prevent cognitive decline and dementia
Abstract Background The Maintain Your Brain (MYB) randomised controlled trial (RCT) aimed to prevent cognitive decline and dementia through a multidomain risk‐reduction intervention delivered digitally. The intervention targeted four modifiable risk areas (physical inactivity, poor diet, cognitive inactivity, and depression and/or anxiety). MYB ran for three years and targeted older Australians aged 55‐77 years. We previously reported significant benefits on cognition in the intervention group compared to the control group. Here we report the outcome on a validated dementia risk assessment tool. Method The self‐reported short form of the Australian National University Alzheimer’s Disease Risk Index (ANU‐ADRI‐SF; 1) was used to assess dementia risk in MYB. To examine risk and protective factors, non‐modifiable factors (age and sex) were removed. Unrealistic values were also removed as part of the data cleaning process. A generalised linear mixed model with appropriate response distributions and link function was run to examine the group (intervention vs control) by time (baseline, 12‐, 24‐, and 36‐months) interaction. An additional analysis adjusted for baseline age, gender, and years of education was run. Result Of 14,064 participants who consented, 6,104 participants were eligible and completed baseline assessments. They were randomised 1:1 to the intervention (n = 3,051) or control (n = 3,053) group. Upon removing outliers (n = 58), 6,046 participants were included in the mixed model analysis. Analysis revealed significant intervention effects on dementia risk change over three years (0.56, 95%CI ‐0.88‐ ‐0.30, p<0.001). Results were replicated in the adjusted model (p<0.001). Conclusion An online intervention program confirmed results from a 24‐month follow‐up of in‐person multicomponent interventions (2,3) in lowering dementia risk. Overall, MYB has the potential to provide a realistic path towards scalable community‐based prevention of dementia, resulting in an improvement in public health and potential economic implications. References : 1. Kim S et al, Alzheimers Dement : Translational Res & Clin Interventions 2016;2:93‐98 2. Barbera et al., Alzheimers Dement J Alzheimers Assoc . 2020; 16:S10 3. Deckers K et al. Alzheimers Dement . 2021;17:1205‐1212.
Authors
- Tiffany Chau (ORCID: https://orcid.org/0000-0002-3469-3672)
- Henry Brodaty (ORCID: https://orcid.org/0000-0001-9487-6617)
- Nancy Briggs (ORCID: https://orcid.org/0000-0002-1134-0807)
- Nicola T. Lautenschlager (ORCID: https://orcid.org/0000-0003-4850-7794)
- Perminder Singh Sachdev (ORCID: https://orcid.org/0000-0002-9595-3220)
- Michael Millard (ORCID: https://orcid.org/0000-0002-0228-9560)
- Gordana Popović (ORCID: https://orcid.org/0000-0002-1376-1058)
- Jeewani Anupama Ginige (ORCID: https://orcid.org/0000-0002-6695-6983)
- Kaarin Jane Anstey (ORCID: https://orcid.org/0000-0002-9706-9316)
- Michael Valenzuela (ORCID: https://orcid.org/0000-0001-7162-6607)
- Louisa Jorm (ORCID: https://orcid.org/0000-0003-0390-661X)
- Megan Heffernan (ORCID: https://orcid.org/0000-0001-8992-8072)
- Maria A. Fiatarone Singh
Institutions
- The University of Sydney (AU)
- The University of Melbourne (AU)
- UNSW Sydney (AU)
- St Vincent's Hospital Sydney (AU)
- The George Institute for Global Health (AU)
- ARC Centre of Excellence in Synthetic Biology (AU)
- Western Sydney University (AU)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.090586
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00